|
Table 1: Paraclinical tests performed during the patient’s hospital stay, among which the elevated value of the tumor marker chromogranin A stands out. |
|
|
09/13/2021 |
|
|
Gastrin, pg/ml |
10.3* |
|
Free insulin, ImU/l |
14.8* |
|
PTH intact molecule, pg/ml |
35* |
|
Total triiodothyronine, ng/ml |
0.7* |
|
Total thyroxine, ug/dl |
7.2* |
|
TSH, IU/ml |
2.83* |
|
HB AC1, % |
5.2* |
|
White blood cells, % Neutrophils Lymphocytes |
8,300 75 15 |
|
Hemoglobin, g/dl |
10.6 |
|
Hematocrit, % |
38 |
|
VCM, um3 |
70 |
|
HCM, pg |
19 |
|
MHC, g/dl |
28 |
|
EDI, % |
19 |
|
Platelets, mm3 |
363,000 |
|
09/15/2021 |
|
|
Chromogranin A, ng/dl (range) |
412 (0-100) |
|
Natriuretic peptide B, pg/dl |
2.25* |
|
PTH = parathyroid hormone. TSH = thyroid stimulating hormone. HB = hemoglobin. MCV = mean corpuscular volume. MCH = mean corpuscular hemoglobin. MCHC = mean corpuscular hemoglobin concentration. EDI = erythrocyte dispersion index. * Normal values. |
|